- Univadis Medical News
- 1 comment
Statins: Do the risks outweigh the benefits in over 65s?
Post hoc analysis of data from the ALLHAT-LLT study of 2,867 participants enrolled at 513 sites.
Recommended in Pharmacists
- Clinical summaries
- 1 comment
- FULLTEXT
Do antidepressants increase VTE risk in women?
- Clinical summaries
- 1 comment
Atherosclerosis: aspirin may be useful among patients with a prior ischaemic event
- Clinical Essentials from Eur Respir J
- no comment
COPD: does combining LAMA and LABA raise CVD risk?
- The Lancet Psychiatry
- no comment
- FULLTEXT
Ketamine treatment for depression: risks and benefits
- Univadis Medical News
- 1 comment
New therapies for psoriatic arthritis get green light
- Univadis Medical News
- 1 comment
Manchester attack: visiting health workers among first to offer assistance
- Univadis Medical News
- no comment
EMA recommends changes to vancomycin prescribing information
- Clinical Essentials from FDA
- no comment
- FULLTEXT
FDA: brain retention of gadolinium not harmful
Professional & Business
- International Medical Press
Study recommends use of ‘digital autopsies’
- International Medical Press
Cannabis-based drug could help treat epilepsy in children
- International Medical Press
Elderly care costs set for steep increase, say researchers
- International Medical Press
GP numbers fall short of targets
- International Medical Press
New GMC standards for postgrad training
- International Medical Press
Testing platelet counts could speed up cancer diagnosis
New in Pharmacists
- The Lancet
- 1 comment
- FULLTEXT
Improvements for global health law trilogy
The global health law trilogy attempts for a safer, healthier, and fairer world
- Clinical Essentials from Urol Oncol
- 1 comment
Prostate cancer: salvage ADT underutilized despite level 1 evidence
RTOG 9601 data published in 2010 showed survival benefit for adding ADT to SRT.
- Clinical Essentials from Liver Int
- 1 comment
HCV: SOF/VEL shows high efficacy, PRO benefit in HIV coinfection
Results of the ASTRAL-5 study.
- Univadis Medical News
- 1 comment
Former Ethiopian health minister elected WHO Director-General
The new Director-General of the World Health Organization will take office on July 1 for a five-year period.
- BMJ News
- 1 comment
Statins may not cut CHD or mortality
Treating older people who have moderate hyperlipidaemia and hypertension with statins for primary prevention of cardiovascular disease does not reduce...
- Clinical Essentials from Leuk Lymphoma
- 1 comment
DLBCL: early interim PET/CT with liver-based assessment more predictive of PFS
Interim scan carried out after 2 cycles of chemotherapy.
- Clinical Essentials from Clin Cancer Res
- 1 comment
Refractory HR+/HER2− MBC: abemaciclib shows promise in phase 2 trial
Abemaciclib is a CDK4 and CDK6 inhibitor given as a single agent.
- Clinical Essentials from Oncotarget
- 1 comment
NSCLC: KRAS+ status predicts OS benefit with checkpoint inhibitors
Results of a meta-analysis show benefit over docetaxel is limited to KRAS-mutant disease.
- Clinical Essentials from Oncologist
- 1 comment
Locally advanced NSCLC: NLR predicts CRT outcomes
Prognostic value observed in patients receiving definitive chemoradiation with or without surgery.
- Monthly Essentials
- 1 comment
Gastrointestinal Disease: Monthly Essentials May 2017
Aginate-antacid + PPI for GERD | Deprescribing PPIs | Managing pain in IBD.
- Conference reports - RSi Communications
- 1 comment
COPD exacerbation in those with CVD may increase stroke risk | ATS
Currently used cardiac medications might be called for immediately following COPD exacerbations.
- Conference reports - RSi Communications
- no comment
Program more than halves catheter-associated UTIs in nursing homes | AGS
CAUTI rates decreased by 54% with 75% of facilities reporting at least 40% reduction
- Clinical Essentials from Gynecol Oncol
- 1 comment
Ovarian granulosa cell tumors: prognostic factors identified
Early surgery is best, and adjuvant chemotherapy does not appear to improve survival.
- Clinical Essentials from Oncotarget
- 1 comment
Metformin stands out among diabetes medications for pancreatic cancer benefit
Meta-analysis of cohort studies finds benefit for metformin only.
